Top anti-abortion activists called for the leader of the Food and Drug Administration to be fired on Tuesday after reports indicated that he is putting off a long-awaited safety review of the abortion pill mifepristone until after the 2026 midterm elections.
Marjorie Dannefelser, president of Susan B. Anthony Pro-Life America, and Lila Rose, president of the anti-abortion group Live Action, said separately on X Tuesday that FDA Commissioner Dr. Marty Makary should be fired after Bloomberg reported with anonymous sources that he is delaying a safety review of the controversial abortion pill.
Makary and Health and Human Services Secretary Robert F. Kennedy Jr. promised congressional Republicans during their confirmation hearings that the Trump administration would undertake a comprehensive safety review of mifepristone following a bombshell report earlier this year that found a complication rate for the pill that is 22 times higher than what is on the FDA’s label for the drug.
In April, the anti-abortion think tank Ethics and Public Policy Center published a review of health insurance claims that found about an 11% complication rate within 45 days of a mifepristone prescription, including life-threatening complications such as sepsis and hemorrhaging.
